iTMS - Implementing Transcranial Magnetic Stimulation (TMS) to Assess Cortico-spinal Tract Integrity
iTMS
1 other identifier
observational
100
1 country
1
Brief Summary
Reliable prediction of upper limb (UL) function can guide clinicians in choosing relevant treatment, helps to set realistic goals for rehabilitation and will contribute to personalized and effective rehabilitation. TMS has been identified as a strong predictor of future UL function after stroke. With this project, the investigators want to implement the standard use of TMS examination for a defined patient group in the clinical setting and systematically evaluate the implementation process. The impact and perceived value of TMS in the clinical setting will be evaluated and the predictive value of TMS for the specific patient population will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2023
CompletedFirst Submitted
Initial submission to the registry
June 14, 2023
CompletedFirst Posted
Study publicly available on registry
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMay 21, 2025
May 1, 2025
2.7 years
June 14, 2023
May 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Action Research Arm Test
Assesses arm motor function, range 0-57 (best)
3 months after stroke
Secondary Outcomes (2)
Shoulder Abduction Finger Extension Test
3 months after stroke
Fugl-Meyer Motor Assessment Upper Limb (0-66 best)
3 months after stroke
Eligibility Criteria
We include patients with stroke and severe paresis or paralysis of an upper limb after stroke.
You may qualify if:
- admitted to rehabilitation within 21 days after stroke
- severe UL impairment, either paralysis (no active movement), or severe paresis, defined as Fugl-Meyer Assessment \<17 or Shoulder Abduction Finger Extension (SAFE) score \< 5
- At least 18 years old
- able to provide informed consent and comply with examination procedures
You may not qualify if:
- Epilepsy
- Metal implants in the head
- Other implanted electronics (cardiac pacemaker, defibrillator, cochlear implant, medication pump)
- Skull fracture or serious head injury
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hammel Neurorehabilitation Centre and University Research Clinic
Hammel, Aarhus, 8450, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD, associate professor
Study Record Dates
First Submitted
June 14, 2023
First Posted
December 1, 2023
Study Start
May 1, 2023
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
May 21, 2025
Record last verified: 2025-05